Evidence map›Paper›PMID 21351804›Full record

ArticleACS nano2011

Probing intracellular biomarkers and mediators of cell activation using nanosensors and bioorthogonal chemistry.

Jered B Haun, Neal K Devaraj, Brett S Marinelli, Hakho Lee, Ralph Weissleder

Abstract read
In one paragraph

Article in ACS nano, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  3. Article
  4. Review
  5. Engineering Prodrug Nanomedicine for Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  6. Magnetic Nanoparticles in Cancer Therapy and Diagnosis.Advanced healthcare materials · 2020
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Molecular extraction in single live cells by sneaking in and out magnetic nanomaterials.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  14. Article
  15. The inverse electron demand Diels-Alder click reaction in radiochemistry.Journal of labelled compounds & radiopharmaceuticals · 2014
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jered B HaunCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, USA.
Neal K Devaraj
Brett S Marinelli
Hakho Lee
Ralph Weissleder

Funding

StatisticsP50CA086355 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2015
$27.8M
The Development of Clinical Grade, Targeted Magnetic NanoparticlesU54CA151884 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BELCHER, ANGELA M. · 2010 to 2014
$11.3M
Magnetic nanoswitches for sensing biomoleculesR01EB004626 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2004 to 2012
$3.2M
Novel Clickdyes for Biomedical SensingR01EB010011 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2010 to 2017
$3.1M
Fast in vivo CLICK chemistries for PET imagingK01EB010078 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEVARAJ, NEAL KRISHNA · 2010 to 2014
$852k
Molecular Detection and Profiling of Circulating Tumor CellsF32CA144139 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HAUN, JERED BRACKSTON · 2010 to 2010
$44k
NCI NIH HHS F32 CA144139NCI NIH HHS F32CA144139NCI NIH HHS P50 CA086355NCI NIH HHS U54 CA 151884NCI NIH HHS U54 CA151884NHLBI NIH HHS HHSN268201000044CNIBIB NIH HHS K01 EB010078NIBIB NIH HHS K01EB010078NIBIB NIH HHS R01 EB 004626NIBIB NIH HHS R01 EB004626NIBIB NIH HHS R01 EB 010011NIBIB NIH HHS R01 EB010011PHS HHS U54 11934
6 · The paper itself

Abstract

Nanomaterials offer unique physical properties that make them ideal biosensors for scant cell populations. However, specific targeting of nanoparticles to intracellular proteins has been challenging. Here, we describe a technique to improve intracellular biomarker sensing using nanoparticles that is based on bioorthogonal chemistry. Using trans-cyclooctene-modified affinity ligands that are administered to semipermeabilized cells and revealed by cycloaddition reaction with tetrazine-conjugated nanoparticles, we demonstrate site-specific amplification of nanomaterial binding. We also show that this technique is capable of sensing protein biomarkers and phosho-protein signal mediators, both within the cytosol and nucleus, via magnetic or fluorescent modalities. We expect the described method will have broad applications in nanomaterial-based diagnostics and therapeutics.

Indexed as

NanoparticlesBiomarkersCell DivisionCell Line, TumorCell SurvivalHumansNuclear Magnetic Resonance, BiomolecularProteinsBiomarkersProteins

Identifiers

PMID21351804
PMCPMC3088084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.